scholarly journals Eyelash in lacrimal punctum: demonstrating a negative pressure in the lacrimal sac

2019 ◽  
Vol 16 (4) ◽  
pp. 319-322
Author(s):  
Anil Kumar Verma ◽  
Avantika Dogra ◽  
Rajeev Tuli
Keyword(s):  
Negative Pressure ◽  
Corneal Stroma ◽  
Lower Eyelid ◽  
Meibomian Gland ◽  
Lacrimal Sac ◽  
Body Hair ◽  
Upper Eyelid ◽  
Subconjunctival Space

Eyelashes are normally arranged in two or three rows on the upper and lower eyelids. They are more numerous on the upper eyelid, with approximately 150 eyelashes being present on the upper and 75 on the lower eyelid. Eyelashes, like body hair, are shed regularly every 100 to 150 days. Usually, the shed eyelashes do not cause any symptoms. However, the cilia may sometimes get misplaced and end up in the lacrimal puncta, meibomian gland orifice, subconjunctival space, and corneal stroma. An eyelash that gets misplaced into the punctum has the potential to cause additional problems. Once the eyelash enters the punctum, the barbs on the hair prevent it from being expelled.  

scholarly journals Concurrent squamous cell carcinoma and hemangiosarcoma in the cornea of a cat

2016 ◽  
Vol 85 (1) ◽  
pp. 31-35
Author(s):  
G. Storms ◽  
C. Naranjo ◽  
M. Grauwels
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Corneal Stroma ◽  
Lower Eyelid ◽  
Upper Eyelid ◽  
Multiple Primary Neoplasms ◽  
Corneal Epithelial ◽  
Primary Neoplasms ◽  
Corneal Biopsy

A 14-year-old, female, spayed Domestic Shorthair cat was presented for evaluation of a dark red mass occupying about 75% of the cornea of the left eye. Furthermore, the eye presented upper eyelid trichiasis, lower eyelid entropion and a marked symblepharon. The fellow eye presented upper eyelid trichiasis, lower eyelid entropion, extensive symblepharon and chronic stromal ulcerative keratitis. Based on the results of a corneal biopsy of the left eye, a corneal squamous cell carcinoma was diagnosed and an enucleation was performed subsequently. Histopathology of the globe revealed the presence of variably sized, vascular-like, blood-filled channels in the superficial corneal stroma, lined by spindle cells. In the central cornea, a markedly hyperplastic epithelium was noticed with infiltration of atypical corneal epithelial cells into the superficial stroma. A primary corneal hemangiosarcoma associated with a primary corneal squamous cell carcinoma was diagnosed. In this case report, the rare presence of multiple primary neoplasms within the same anatomical structure is described.

scholarly journals Impact of pterygium on the ocular surface and meibomian glands

2019 ◽  
Author(s):  
Ana Cláudia Viana Wanzeler ◽  
Italo Antunes França Barbosa ◽  
Bruna Duarte ◽  
Eduardo Buzolin Barbosa ◽  
Daniel Almeida Borges ◽  
...  
Keyword(s):  
Ocular Surface ◽  
Tear Film ◽  
Lower Eyelid ◽  
Meibomian Gland ◽  
Conjunctival Hyperemia ◽  
Upper Eyelid ◽  
Film Stability ◽  
Surface Parameters ◽  
Meibomian Glands ◽  
The Impact

AbstractPurposeTo analyze how ocular surface parameters correlate to pterygium and investigate the possible impact on tear film and meibomian glands.Methodswe investigated objective parameters of the ocular surface such as conjunctival hyperemia, tear film stability and volume, meibomian gland dysfunction, dry eye disease, corneal topography comparing healthy individuals and correlating with the pterygium clinical presentation.ResultsA total of 83 patients were included. Corneal astigmatism induction was 2.65 ± 2.52 D (0.4-11.8). The impact of pterygium on the ocular surface parameters compared to matched controls was seen in: conjunctival hyperemia (control 1.55±0.39/pterygium 2.14±0.69; p=0.0001), tear meniscus height (control 0.24±0.05 mm/pterygium 0.36±0.14mm; p 0.0002), meiboscore lower eyelid (control 0.29±0.64/pterygium 1.38±0.95; p 0.0001) and meiboscore upper eyelid (control 0.53±0.62/pterygium 0.98±0.75; p=0.0083). We found a high number of pterygium patients (88%) presented meibomian gland alterations. Interestingly, meibomian gland loss was coincident to the localization of the pterygium in 54% of the upper and 77% lower lids.ConclusionPterygium greatly impacts on ocular surface by inducing direct alterations in the pattern of meibomian glands besides corneal irregularities, conjunctival hyperemia and lacrimal film alterations, inducing significant symptoms and potential signs of dysfunction.

scholarly journals Meibomian gland carcinoma of the lower eyelid: a rare case

2020 ◽  
Vol 8 (11) ◽  
pp. 4152
Author(s):  
Madhusmita Behera ◽  
Subhra Dhar
Keyword(s):  
Rare Case ◽  
Sebaceous Gland ◽  
Lower Eyelid ◽  
Meibomian Gland ◽  
Upper Eyelid ◽  
Tarsal Plate ◽  
Inappropriate Treatment ◽  
Gland Carcinoma ◽  
Meibomian Glands ◽  
Slow Growing

Meibomian gland carcinoma (MGC) is a rare but highly malignant slow growing tumor of the eyelid. MGC usually arises from meibomian gland located in the tarsal plate although rarely it can originates in the gland of zeis, sebaceous gland of caruncle, and periocular skin. MGC is more common in cases of elderly females. Upper eyelid is more commonly affected where the meibomian glands are more. Early diagnosis is very important but in most of the cases the diagnosis is delayed as it mimics chalazion or blepharo-conjunctivitis. This leads to inappropriate treatment and increase in morbidity and/or mortality. Special feature of this carcinoma is that it spread intra-epithelial and causes skipped lesions.

scholarly journals Bilateral primary eyelid meibomian gland epithelioma in a dog: a case report

2019 ◽  
Vol 70 (1) ◽  
pp. 1435
Author(s):  
A. KOMNENOU ◽  
G. CHARALAMBIDOU ◽  
S. MAKROGKIKAS ◽  
N. PAPAIOANNOU
Keyword(s):  
Lower Eyelid ◽  
Meibomian Gland ◽  
Surgical Removal ◽  
Upper Eyelid ◽  
Palpebral Conjunctiva ◽  
Lateral Canthus ◽  
Tarsal Glands ◽  
The Right ◽  
Left Eyelid ◽  
Periorbital Swelling

In this paper an extremely rare case of primary bilateral eyelid meibomian gland epithelioma in a dog is presented. Meibomian tumors arise from the meibomian (tarsal) glands on the inner aspect of the eyelid, and meibomian gland adenomas and adenocarcinomas are the most frequent neoplasia arising from those glands. A 10-year-old male dog was admitted, with ophthalmic signs of periorbital swelling of the right eye. During the last two years, the dog had a progressive engorgement of the upper eyelid of the right eye, and during the past few months, strabismus and exophthalmos were also noticed, as well as a slighter enlargement on the lower eyelid of the left eye. Upon ophthalmic examination strabismus and periorbital swelling at the lateral canthus of the right eye, accompanied by mild exophthalmos and lagophthalmos, were recorded. Also, deep ulcerative keratitis with corneal oedema and neovascularization were noticed. Intense chemosis, epiphora and a small pinkish mass arising from the palpebral conjunctiva of the left lower eyelid were also seen. Neoplasia of both eyelids was suspected, and a series of diagnostic examinations were carried out. Orbital exenteration of the right eye was performed in the first place, followed by surgical removal of the mass of the left eyelid one month later. Based on clinical and histopathological findings, meibomian gland epithelioma was diagnosed. No relapse or metastases (local or distant) were observed in re-examinations within 18 months after the surgery. This study shows that although meibomian gland epithelioma is rare, it should be considered in the differential diagnosis of cases of orbital and eyelid tumors. Even though this tumor shows low malignancy, prompt surgical intervention and extended excision is the treatment of choice, in order to preserve vision in some cases. To the authors’ knowledge, the present case is the first report of bilateral meibomian gland epithelioma in the veterinary literature.

RESULTS OF INTRALESIONAL TRIAMCINOLONE ACETONIDE FOR CHALAZION TREATMENT

2011 ◽  
pp. 100-104
Author(s):  
Thi Thu Nguyen ◽  
Viet Hien Vo ◽  
Thi Em Do
Keyword(s):  
Success Rate ◽  
Key Words ◽  
Triamcinolone Acetonide ◽  
Lower Eyelid ◽  
Upper Eyelid ◽  
Interventional Trial ◽  
The Mean ◽  
First Time

The study use intralesional triamcinolone acetonide injection proceduce for chalazion treatment.1. Objectives: To evaluate results of intralesional triamcinolone acetonide injection for chalazion treatment. 2. Method: This noncomparative prospective interventional trial included 72 chalazions of 61 patients. 3. Results: 61 patients (72 chalazions) with 19 males (31.1%) và 42 females (68.9%), the mean age was 24 ± 9,78 years. 31.1% patients was the first time chalazion and 68.9% patients was more than one times chalazion including 78.6% patients was recurrent at the first position and 21.4% patients occur at new position. 72 chalazions with 16 (22.2%) chalazions was treated before and 56 (77.8%) chalazions wasn’t done that. 72 chalazions with 49 chalazions (68.1%) are local in upper eyelid and 23 chalazions (31.9%) are local in lower eyelid. The mean of chalazion diameter is 6.99 ± 3.03mm. Intralesional triamcinolone acetonide is injected to treat 72 chalazions with 16 (22.2%) chalazions are injected through the route of skin and 56 (77.8%) chalazions are injected through the route of conjunctiva. After 2 weeks follow-up, the success rate was 93.1% and 6.9% failed. 4. Conclusion: intralesional triamcinolone acetonide injection for chalazion treatment is really effective. Key words: chalazion, intralesional triamcinolone acetonide.

Upper Eyelid Approach to Lower Eyelid Blepharoplasty

2010 ◽  
Vol 126 (5) ◽  
pp. 1752-1755 ◽  
Author(s):  
Mehryar Taban ◽  
Ronald Mancini ◽  
Catherine Hwang ◽  
Robert A. Goldberg
Keyword(s):  
Lower Eyelid ◽  
Upper Eyelid

Changes to Eye Whiteness and Eyelid/Brow Position With Topical Oxymetazoline in Aesthetic Patients

2021 ◽  
Author(s):  
Shoaib Ugradar ◽  
Jane S Kim ◽  
Noelle Trost ◽  
Emanuil Parunakian ◽  
Erin Zimmerman ◽  
...  
Keyword(s):  
Color Change ◽  
Color Space ◽  
Ophthalmic Solution ◽  
The United States ◽  
Lower Eyelid ◽  
Secondary Outcome ◽  
Level Of Evidence ◽  
Upper Eyelid ◽  
Before And After ◽  
The Mean

Abstract Background Oxymetazoline hydrochloride 0.1% ophthalmic solution has recently been approved in the United States for the treatment of ptosis. Objectives The aim of this study was to assess the upper and lower eyelid position as well as the brow position and the color of the sclera following the ophthalmic administration of oxymetazoline hydrochloride 0.1%. Methods In this prospective cohort study, consecutive patients presenting with ptosis received topical oxymetazoline 0.1%. The primary outcome was measurement of the upper eyelid height (margin-to-reflex distance 1 [MRD1]) and lower eyelid height (MRD2) relative to the center of pupil, along with assessment of brow height, measured on photographs at baseline and 2 hours after instillation of oxymetazoline. The secondary outcome was the assessment of the color of the sclera (eye whiteness) before and after treatment with a novel color space algorithm. Results Twenty-nine patients participated in the study. The mean [SD] MRD1 at baseline was 2.3 [0.6] mm. At 2 hours following oxymetazoline treatment, the mean MRD1 significantly increased to 4.2 [0.9] mm (P < 0.01). The mean MRD2 also significantly increased from 5.3 [0.9] mm to 5.7 [1.0] mm (P < 0.01). Brow position did not change with treatment (P = 0.4). Following treatment, the eye sclera became significantly whiter, with a mean ΔEab (color change) of 9.7 [3.9], with 57 out of 58 eyes experiencing a significant change in color. A change of ΔEab ≥2 is considered visually perceptible to the human eye. Conclusions Within 2 hours of use, oxymetazoline significantly improves the size of the palpebral aperture (MRD1 + MRD2) and also makes the eye appear significantly whiter. Level of Evidence: 4

scholarly journals Synchronous Surgical Treatment of Lower Eyelid Involutional Entropion and Ptosis

2018 ◽  
Vol 2018 ◽  
pp. 1-3
Author(s):  
D. Vasakos ◽  
E. Nakos ◽  
C. Sioulis
Keyword(s):  
Treatment Options ◽  
The Elderly ◽  
Lower Eyelid ◽  
Postoperative Recovery ◽  
Multiple Time ◽  
Upper Eyelid ◽  
Alternative Treatment Strategy ◽  
Involutional Entropion ◽  
Lateral Tarsal Strip ◽  
Upper Eyelid Ptosis

Background. Involutional entropion and upper eyelid ptosis are common eyelid diseases in the elderly population. They represent a frequent cause of discomfort and often result in significant visual and functional impairment. The surgical management of these disorders includes various treatment options and techniques and is usually carried out in multiple time sessions. Case Report. We report the case of a 72 year old female patient, suffering from right eye involutional lower eyelid entropion and ptosis, who was treated synchronously for both conditions, by applying the lateral tarsal strip procedure and the levator resection technique. Conclusion. The synchronous treatment of involutional entropion and ptosis is an alternative treatment strategy, which could potentially improve surgical outcome, while reducing postoperative recovery time and treatment costs.

Sign in / Sign up

Export Citation Format

Share Document